Page last updated: 2024-08-23

paclitaxel and Cognition Disorders

paclitaxel has been researched along with Cognition Disorders in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boehmerle, W; Endres, M; Freyer, D; Huehnchen, P; Springer, A1
Crystal, JD; Hohmann, AG; Slivicki, RA; Smith, AE1
Boyette-Davis, JA; Fuchs, PN1
Etheridge, AS; Kroll, DJ; Mathews, JM1
Bird, TD; Boutté, AM; Montine, KS; Montine, TJ; Neely, MD1
Dodd, M; Dowling, G; Jansen, C; Kramer, J; Miaskowski, C1
Aghajanian, C; Chi, DS; Correa, DD; Dupont, J; Hensley, ML; Sabbatini, P; Spriggs, D; Thaler, H; Venkatraman, E; Wilton, A1
Perry, JR; Warner, E1
Cairncross, JG; Fortin, D; Macdonald, DR; Stitt, L1

Reviews

2 review(s) available for paclitaxel and Cognition Disorders

ArticleYear
Potential mechanisms for chemotherapy-induced impairments in cognitive function.
    Oncology nursing forum, 2005, Nov-03, Volume: 32, Issue:6

    Topics: Anemia; Animals; Antineoplastic Agents; Attention; Blood-Brain Barrier; Cognition Disorders; Cyclophosphamide; Doxorubicin; Encephalitis; Fluorouracil; Humans; Inflammation; Language; Learning; Memory; Menopause; Methotrexate; Neoplasms; Oncology Nursing; Paclitaxel; Psychomotor Performance; Spatial Behavior

2005
Transient encephalopathy after paclitaxel (Taxol) infusion.
    Neurology, 1996, Volume: 46, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Brain Diseases; Breast Neoplasms; Cognition Disorders; Electroencephalography; Fatal Outcome; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Paclitaxel

1996

Trials

1 trial(s) available for paclitaxel and Cognition Disorders

ArticleYear
Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.
    Gynecologic oncology, 2006, Volume: 102, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cognition; Cognition Disorders; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Longitudinal Studies; Middle Aged; Ovarian Neoplasms; Paclitaxel; Quality of Life

2006

Other Studies

6 other study(ies) available for paclitaxel and Cognition Disorders

ArticleYear
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice.
    Translational psychiatry, 2017, 08-01, Volume: 7, Issue:8

    Topics: Animals; Calcium; Calpain; Caspase 3; Cell Proliferation; Cognition Disorders; Hippocampus; Humans; Lithium Carbonate; Memory Disorders; Mice; Mice, Inbred C57BL; Neural Stem Cells; Paclitaxel

2017
The chemotherapeutic agent paclitaxel selectively impairs learning while sparing source memory and spatial memory.
    Behavioural brain research, 2017, 03-01, Volume: 320

    Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cognition Disorders; Learning Disabilities; Male; Maze Learning; Memory, Episodic; Paclitaxel; Physical Stimulation; Rats; Rats, Long-Evans; Spatial Memory

2017
Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity.
    Neuroscience letters, 2009, Apr-10, Volume: 453, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cognition; Cognition Disorders; Conditioning, Operant; Male; Paclitaxel; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Long-Evans; Reaction Time

2009
Inhibition of paclitaxel metabolism in vitro in human hepatocytes by Ginkgo biloba preparations.
    Journal of dietary supplements, 2009, Volume: 6, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Cognition Disorders; Dose-Response Relationship, Drug; Ginkgo biloba; Hepatocytes; Herb-Drug Interactions; Humans; Neoplasms; Paclitaxel; Plant Preparations

2009
Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive
    Journal of Alzheimer's disease : JAD, 2005, Volume: 8, Issue:1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Chromosomes, Human, Pair 17; Cognition Disorders; Dementia; DNA Mutational Analysis; Female; Genetic Linkage; Humans; Male; Membrane Proteins; Microtubule-Associated Proteins; Microtubules; Paclitaxel; Parkinsonian Disorders; Presenilin-2; tau Proteins; Tubulin; Tubulin Modulators

2005
PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2001, Volume: 28, Issue:3

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cisplatin; Cognition Disorders; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Multivariate Analysis; Oligodendroglioma; Paclitaxel; Prognosis; Survival Analysis; Taxoids; Vinblastine

2001